0001209191-23-039426.txt : 20230623
0001209191-23-039426.hdr.sgml : 20230623
20230623164046
ACCESSION NUMBER: 0001209191-23-039426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230622
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Croarkin Richard
CENTRAL INDEX KEY: 0001641815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 231038322
MAIL ADDRESS:
STREET 1: C/O AERIE PHARMACEUTICALS, INC.
STREET 2: 2030 MAIN STREET, SUITE 1500
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-270-3631
MAIL ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-22
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001641815
Croarkin Richard
C/O CLEARSIDE BIOMEDICAL, INC.
900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA
GA
30005
1
0
0
0
0
Stock Option (right to buy)
1.31
2023-06-22
4
A
0
30000
0.00
A
2033-06-21
Common Stock
30000
30000
D
The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2024, subject to the Reporting Person's continuous service as of such vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2023-06-23